2014 Annual Meeting | Aging, Dementia, and Cognitive and Behavioral Neurology: Dementia Genetics
02:00 PM - 03:45 PM | Abstract |
002 - Late-onset Alzheimer disease neuropathology genomic screen identifies novel loci for neuritic plaque and other AD neuropathology features
Gary W. Beecham, PhD |
02:00 PM - 03:45 PM | Abstract |
003 - Whole-exome sequencing of Hispanic early-onset Alzheimer disease families identifies rare variants in multiple Alzheimer-related genes
Christiane Reitz, MD, PhD |
02:00 PM - 03:45 PM | Abstract |
004 - The Dissection of High-Penetrance Variants in extended Late-Onset Alzheimer Disease Families by Whole-Exome Sequencing
Martin A. Kohli |
02:00 PM - 03:45 PM | Abstract |
005 - Transcript profiling analysis of Alzheimer's disease brains.
Mariet Allen, PhD |
02:00 PM - 03:45 PM | Abstract |
006 - Investigation of transcriptional regulation at the Alzheimer's disease risk loci.
Michaela Kachadoorian |
02:00 PM - 03:45 PM | Abstract |
007 - Screening for NOTCH3 Mutation in Patients with Subcortical Vascular Cognitive Impairment
Cindy Yoon |
Nilufer Taner, MD, PhD, FAAN | The institution of Dr. Taner has received research support from NIH. |
Jeffery Vance, MD, PhD | Dr. Vance has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for neurology genetics. |
Dennis W. Dickson, MD | Dr. Dickson has nothing to disclose. |
Ronald C. Petersen, MD, PhD, FAAN | Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities. |
Duk L. Na, MD | No disclosure on file |
Neill R. Graff-Radford, MD, FAAN | The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Novartis. The institution of Dr. Graff-Radford has received research support from AbbVie. Dr. Graff-Radford has received publishing royalties from a publication relating to health care. |
Sangwon Seo, MD | No disclosure on file |
No disclosure on file | |
Mariet Allen, PhD | No disclosure on file |
Minerva Carrasquillo | Minerva Carrasquillo has nothing to disclose. |
Steven G. Younkin, MD, PhD | No disclosure on file |
Michaela Kachadoorian | No disclosure on file |
Jonathan Haines, MD | No disclosure on file |
Thomas J. Montine, MD, PhD | Dr. Montine has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Enable Medicine. Dr. Montine has stock in Enable Medicine. The institution of Dr. Montine has received research support from NIH. The institution of Dr. Montine has received research support from MJFF. Dr. Montine has received intellectual property interests from a discovery or technology relating to health care. Dr. Montine has received publishing royalties from a publication relating to health care. |
Cindy Yoon | No disclosure on file |
Gary W. Beecham, PhD | The institution of Dr. Beecham has received research support from NIH. The institution of an immediate family member of Dr. Beecham has received research support from NIH. |
Stephan Zuchner, MD, FAAN | Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care. |
Margaret A. Pericak-Vance, PhD | Dr. Pericak-Vance has nothing to disclose. |
Adam Naj, PhD | No disclosure on file |
Martin A. Kohli | No disclosure on file |
Patrice Whitehead | No disclosure on file |
Christiane Reitz, MD, PhD | No disclosure on file |
Lindsay A. Farrer, MD | No disclosure on file |
Richard P. Mayeux, MD, MSc, FAAN | Dr. Mayeux has nothing to disclose. |
Brian D. Moseley, MD | Dr. Moseley has received personal compensation for serving as an employee of UCB. Dr. Moseley has received personal compensation for serving as an employee of Neurocrine Biosciences Inc. Dr. Moseley has stock in UCB. Dr. Moseley has stock in Neurocrine Biosciences. |
Gerard Schellenberg, PhD | No disclosure on file |
Badri Vardarajan | Badri Vardarajan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kodikaz Therapeutics. |
Gilbert R. Gonzales, MD | No disclosure on file |